Paris · Stocky rates: Cautious

EUROFINS SCIENT. (ERF.PA)

€75.54 ▲ +0.91% as of 6 Oct, 06:53

Stocky turns companies like EUROFINS SCIENT. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
40
/ 100
Neutral

What Stocky thinks

Stocky rates EUROFINS SCIENT. at 40/100 based on business quality, leadership alignment, valuation.

Compounder Score
43/100
Business quality — profitability, growth, capital efficiency.
Moat Score
40/100
Competitive advantage — pricing power, switching costs, network effects.
Resilience
50/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
43/100
Valuation vs peers and history — is this a good price to pay?
B+
Sound — solid overall, with one or two weaker areas.

How safely EUROFINS SCIENT. is financed, graded A++ (strongest) to C from the last five years of accounts: debt against earnings, interest cover, cash against debt, how high and steady profit margins are, return on capital, and whether it generated cash every year. Not part of the Stocky score.

What Stocky gives investors that other tools don't

Every stock is scored across six dimensions built to answer one question — can this business keep compounding? — without a Bloomberg subscription. Here's the actual snapshot for EUROFINS SCIENT.:

40
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation fused into a single 0–100 number. When you see 40/100, you know instantly whether to dig deeper or skip.

Limited
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

—
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

50
RESILIENCE

Resilience Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

We don't claim a backtest. The top-scoring basket is recorded every month and measured against the S&P 500 from that date onward — judged on what it said before the outcome was known. The record is young, and published as it stands.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

EUROFINS SCIENT. (ERF.PA) — frequently asked

Is EUROFINS SCIENT. (ERF.PA) a good investment right now?

Stocky rates EUROFINS SCIENT. (ERF.PA) at 40/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation into a single number.

What is ERF.PA's Stocky Verdict?

ERF.PA's current Stocky Verdict is 40/100, placing it in the "Cautious" band. This composite combines a 43/100 Compounder score, Leadership, 40/100 Moat rating.

Does EUROFINS SCIENT. have a competitive moat?

EUROFINS SCIENT. rates Limited moat (40/100 Moat Score) — based on 10-year return-on-invested-capital, pricing power, switching costs and network effects. Wide moats compound; Limited moats erode.

Is EUROFINS SCIENT.'s leadership aligned with shareholders?

Leadership Alignment for EUROFINS SCIENT. is under analysis. Stocky scores founder tenure, insider ownership, CEO compensation multiple-of-salary, and long-term shareholder value creation.

What are the biggest risks to ERF.PA?

EUROFINS SCIENT.'s Resilience Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to EUROFINS SCIENT..

This is just the surface. See the whole picture on EUROFINS SCIENT..

Sign up free and unlock the full analysis on ERF.PA — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering ERF.PA — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Resilience Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for ERF.PA.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how ERF.PA changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to ERF.PA?" · "Is ERF.PA overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
40
/ 100 · Neutral

See EUROFINS SCIENT. the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in ERF.PA would be worth today.
Practice portfolio
Buy ERF.PA with virtual money and track it — zero risk.
Free · no real money · learn by doing Open ERF.PA in Stocky →

Or jump straight to the interactive dashboard for ERF.PA in the app.